Literature DB >> 14159259

CONTROLLED STUDY OF PSYCHIATRIC OUTPATIENT TREATMENT.

N Q BRILL, R R KOEGLER, L J EPSTEIN, E W FORGY.   

Abstract

Entities:  

Keywords:  CLINICAL RESEARCH; HOSPITAL OUTPATIENT CLINICS; HOSPITALS, PSYCHIATRIC; MEPROBAMATE; MMPI; NEUROSES; PHENOBARBITAL; PLACEBOS; PROCHLORPERAZINE; PSYCHOTHERAPY; SCHIZOPHRENIA

Mesh：

Substances：

Year:  1964        PMID： 14159259     DOI： 10.1001/archpsyc.1964.01720240035006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  7 in total

Review 1.  Measurement of personality and attitude: applications to clinical research.

Authors:  I Marks
Journal:  Postgrad Med J       Date:  1968-04       Impact factor: 2.401

2.  Controlled psychoparmacological research in private psychiatric practice.

Authors:  K Rickels; R B Cattell; C Weise; B Gray; R Yee; A Mallin; H G Aaronson
Journal:  Psychopharmacologia       Date:  1966

3.  Community mental health treatment: what works for whom?

Authors:  J Braff; M M Lefkowitz
Journal:  Psychiatr Q       Date:  1979

Review 4.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

Review 5.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  Psychotherapy research.

Authors:  H G Jones
Journal:  J R Soc Med       Date:  1985-01       Impact factor: 18.000

Review 7.  Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Authors:  Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho
Journal:  Ther Clin Risk Manag       Date:  2017-06-29       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.